ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 279 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $216,000 | -79.4% | 15,354 | -65.9% | 0.02% | -83.2% |
| Q4 2021 | $1,050,000 | -8.8% | 44,980 | -4.7% | 0.11% | -4.5% |
| Q2 2021 | $1,151,000 | +93.4% | 47,189 | +284.1% | 0.11% | +62.3% |
| Q2 2020 | $595,000 | -32.5% | 12,285 | -40.4% | 0.07% | -19.8% |
| Q4 2019 | $881,000 | -46.9% | 20,601 | -55.3% | 0.09% | -33.3% |
| Q3 2019 | $1,660,000 | +230.0% | 46,114 | +146.2% | 0.13% | +360.7% |
| Q1 2019 | $503,000 | +35.2% | 18,727 | -18.5% | 0.03% | +40.0% |
| Q4 2018 | $372,000 | – | 22,975 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| March Altus Capital Management LP | 82,723 | $2,685,000 | 20.75% |
| HWG Holdings LP | 289,380 | $9,393,000 | 8.72% |
| Baker Brothers Advisors | 24,516,738 | $795,813,000 | 8.34% |
| HARVEY CAPITAL MANAGEMENT INC | 352,200 | $11,432,000 | 5.73% |
| Belmont Global Advisors, Inc. | 150,000 | $4,869,000 | 4.67% |
| Palo Alto Investors LP | 1,437,730 | $46,669,000 | 3.52% |
| Avoro Capital Advisors LLC | 329,500 | $10,696,000 | 2.38% |
| GARRISON BRADFORD & ASSOCIATES INC | 70,100 | $2,275,000 | 2.23% |
| WEATHERBIE CAPITAL, LLC | 401,642 | $13,037,000 | 1.85% |
| ACUTA CAPITAL PARTNERS, LLC | 85,999 | $2,792,000 | 1.34% |